体外循环在胸心创伤中的全国使用情况:国家创伤数据库回顾性分析
本研究基于国家创伤数据库2010—2015年数据,纳入成人胸心创伤且在入院24小时内行手术修复的患者共28,481例,其中319例使用体外循环(CPB)。未使用CPB者住院死亡风险显著更高(OR 1.57,95%CI 1.16-2.12,P=0.003),但并发症显著更低(OR 0.63,95%CI 0.47-0.86,P=0.003)。两组住院时长和ICU时长无显著差异。结论认为CPB用于选择性胸心创伤的早期管理可能与生存获益相关,但需进一步研究明确具体获益损伤类型。
要点
- 在成人胸心创伤入院24小时内行手术修复的患者中,使用CPB者住院死亡风险显著低于未使用者(OR 1.57,95%CI 1.16-2.12,P=0.003,指向未使用CPB者死亡风险更高)。
- CPB组并发症风险显著高于未使用CPB组(OR 0.63,95%CI 0.47-0.86,P=0.003,指向未使用CPB者并发症更低)。
- 匹配后CPB组与非CPB组住院时长(14.7±15.1天 vs 13.4±16.3天,P=0.23)和ICU时长(10.1±9.7天 vs 9.9±10.7天,P=0.08)无显著差异。
- 总体住院死亡率为35%,该数据来自匹配前后的整体队列描述,需结合伤情严重度解读。
- 研究为回顾性数据库分析,证据等级为治疗性IV级,不能据此确立CPB的常规适应证,具体哪些胸心损伤最获益尚不明确。
适用人群与场景
- 纳入:国家创伤数据库2010—2015年登记的成人胸心创伤患者,且在入院24小时内接受手术修复。
- 排除:原文未提及具体排除标准。
- 场景:急诊/创伤中心初始救治阶段,涉及入院24小时内是否使用CPB。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及具体CPB启动标准、药物剂量或流程;仅描述在入院24小时内对胸心创伤行手术修复的部分患者中使用了CPB。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:国家创伤数据库回顾性分析,使用倾向性评分匹配。
- 人群:成人胸心创伤且在入院24小时内行手术修复者。
- 干预与对照:入院24小时内接受CPB vs 未接受CPB的相似损伤患者。
- 主要终点结果:总体住院死亡率为35%;未接受CPB者住院死亡风险显著高于接受CPB者(OR 1.57,95%CI 1.16-2.12,P=0.003)。
- 关键次要终点:未接受CPB者并发症显著低于接受CPB者(OR 0.63,95%CI 0.47-0.86,P=0.003);住院时长(非CPB 13.4±16.3天 vs CPB 14.7±15.1天,P=0.23)和ICU时长(非CPB 9.9±10.7天 vs CPB 10.1±9.7天,P=0.08)无显著差异。
- 不良事件:原文仅报告并发症总体比较,未列出具体并发症类型及发生率。
证据类型、等级与局限
- 证据类型:回顾性数据库分析(非RCT)。
- 证据等级:原文标注Level of Evidence: Therapeutic, level IV。
对床旁实践的改变
- 该研究提示在选择性成人胸心创伤患者中,入院24小时内使用CPB与住院生存获益相关,但并发症更多;不能据此将CPB常规用于所有胸心创伤。
- 适用人群为成人胸心创伤且在入院24小时内行手术修复者;不适用于原文未纳入的人群(如非成人、未在24小时内手术者)。
- 常见陷阱:将观察性关联误读为因果获益;忽视CPB组并发症显著更高;不能把研究中的CPB使用情况当作通用推荐指征。
指南或共识出处
- 原文未提及具体指南或共识名称;仅提及美国外科学院创伤委员会(American College of Surgeons Committee on Trauma)要求所有I级创伤中心具备即刻可用的CPB能力。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The American College of Surgeons Committee on Trauma requires that all level I trauma centers have cardiopulmonary bypass (CPB) capabilities immediately available. Despite this mandate, there are limited data on the utilization and clinical outcomes among trauma patients requiring CPB in the management of injuries. The aim of this study was to evaluate the current use of CPB in the care of trauma patients.
METHODS: This is a retrospective analysis of the National Trauma Data Bank from 2010 to 2015. Adult patients sustaining cardiothoracic injuries who underwent surgical repair within the first 24 hours of admission were included. Propensity score matching was used to compare outcomes (in-hospital mortality, hospital length of stay (LOS), intensive care unit LOS, and complications) between patients who underwent CPB within the first 24 hours of admission and those with similar injuries who did not receive CPB.
RESULTS: A total of 28,481 patients who met the inclusion criteria were identified, of whom 319 underwent CPB. Three-hundred three CPB patients were matched to 895 comparison patients who did not undergo CPB. Overall in-hospital mortality was 35%. Patients who were not treated with CPB had a significantly higher in-hospital mortality compared with those treated with CBP (odds ratio, 1.57; 95% confidence interval, 1.16-2.12; p = 0.003); however, complications were significantly lower in those who did not receive CPB (odds ratio, 0.63; 95% confidence interval, 0.47-0.86; p = 0.003). Hospital LOS (non-CPB: mean, 13.4 ± 16.3 days; CPB: mean, 14.7 ± 15.1 days; p = 0.23) and intensive care unit LOS (non-CPB: mean, 9.9 ± 10.7 days; CPB: mean, 10.1 ± 9.7 days; p = 0.08) did not differ significantly between groups.
CONCLUSION: The use of CPB in the initial management of select cardiothoracic injuries is associated with a survival benefit. Further investigation is required to delineate which specific injuries would benefit the most from the use of CPB.
LEVEL OF EVIDENCE: Therapeutic, level IV.
参考来源
- Johnson BP, Hojman HM, Mahoney EJ, et al. Nationwide utilization of cardiopulmonary bypass in cardiothoracic trauma: A retrospective analysis of the National Trauma Data Bank. J Trauma Acute Care Surg. 2021. PMID: 34137746. doi:10.1097/TA.0000000000003315
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。